Contemporary OB/GYN week in review: autism, perinatal depression, and more
Review some of the top stories from the Contemporary OB/GYN website over the last week, and catch up on anything you may have missed.
Contemporary OB/GYN week in review: autism, perinatal depression, and more
Thank you for visiting the Contemporary OB/GYN® website. Take a look at some of our top stories from last week (Monday, January 22 - Friday, January 16, 2023), and click each link to read and watch anything you may have missed.
1.) Autistic traits among women linked to increased preterm births
A cohort analysis suggests autism may be poorly diagnosed among expectant mothers—and linked to poor birth outcomes.
Click here for the full article.
2.) Perinatal depression linked to suicidal behavior
A recent study indicated perinatal depression significantly increases the risk of suicidal behavior, particularly within the first year post-diagnosis, emphasizing the need for targeted interventions in this vulnerable population.
Click here for the full article.
3.) New guidelines revealed for no-cost FDA-approved contraceptives
The Biden-Harris administration, has released comprehensive guidance through Frequently Asked Questions to eliminate barriers to contraception, ensuring access to FDA-approved contraceptives at no cost, following President Biden's 2023 Executive Order.
Click here for the full article.
4.) Laser ablation for vasa previa shows promising results
A recent study highlighted the potential of fetoscopic laser ablation in improving perinatal outcomes for vasa previa, reducing risks associated with this condition affecting approximately 5 in 10,000 pregnancies.
Click here for the full article.
5.) COVID-19 vaccine dosing impact on maternal and infant antibodies
A recent study revealed that patients with 3 or more COVID-19 vaccination doses exhibit a significant increase in cord anti-Spike antibody levels compared to those with 2 doses.
Ulipristal plus misoprostol shows promise for medication abortion
February 5th 2025A recent study found that ulipristal acetate followed by misoprostol is a safe, effective, and acceptable option for medication abortion, offering a potential alternative in areas with limited access to mifepristone.
Read More
Recap on reproductive rights with David Hackney, MD, MS
December 20th 2022In this episode of Pap Talk, we spoke with David Hackney, MD, MS, maternal-fetal medicine physician at Case Western Reserve University and chair of ACOG's Ohio chapter for a full recap of where restrictions on reproductive rights have been and where they're going.
Listen
In this episode of Pap Talk, Gloria Bachmann, MD, MSc, breaks down what it means to be a health care provider for incarcerated individuals, and explores the specific challenges women and their providers face during and after incarceration. Joined by sexual health expert Michael Krychman, MD, Bachmann also discusses trauma-informed care and how providers can get informed.
Listen
